Cost-effectiveness of hepatitis C treatment for patients in early stages of liver disease
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cost-effectiveness of hepatitis C treatment for patients in early stages of liver disease
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 61, Issue 6, Pages 1860-1869
Publisher
Wiley
Online
2015-02-13
DOI
10.1002/hep.27736
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chronic Hepatitis C Virus Infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010
- (2014) Maxine M. Denniston et al. ANNALS OF INTERNAL MEDICINE
- Mortality Among Persons in Care With Hepatitis C Virus Infection: The Chronic Hepatitis Cohort Study (CHeCS), 2006-2010
- (2014) R. Mahajan et al. CLINICAL INFECTIOUS DISEASES
- Hospitalizations And Costs Associated With Hepatitis C And Advanced Liver Disease Continue To Increase
- (2014) Fujie Xu et al. HEALTH AFFAIRS
- Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141)
- (2014) Sylvie Deuffic-Burban et al. JOURNAL OF HEPATOLOGY
- The Cost-Effectiveness of Birth-Cohort Screening for Hepatitis C Antibody in U.S. Primary Care Settings
- (2013) David B. Rein et al. ANNALS OF INTERNAL MEDICINE
- New Protease Inhibitors for the Treatment of Chronic Hepatitis C
- (2013) Shan Liu et al. ANNALS OF INTERNAL MEDICINE
- The Increasing Burden of Mortality From Viral Hepatitis in the United States Between 1999 and 2007
- (2013) Kathleen N. Ly et al. ANNALS OF INTERNAL MEDICINE
- Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma
- (2013) Rebecca L. Morgan et al. ANNALS OF INTERNAL MEDICINE
- Cost Effectiveness of Direct-Acting Antiviral Therapy for Treatment-Naive Patients With Chronic HCV Genotype 1 Infection in the Veterans Health Administration
- (2013) Kee Chan et al. Clinical Gastroenterology and Hepatology
- Noninvasive Serum Fibrosis Markers for Screening and Staging Chronic Hepatitis C Virus Patients in a Large US Cohort
- (2013) S. D. Holmberg et al. CLINICAL INFECTIOUS DISEASES
- Cost-effectiveness of Screening for Chronic Hepatitis C Infection in the United States
- (2013) Mark H. Eckman et al. CLINICAL INFECTIOUS DISEASES
- The impact of timing and prioritization on the cost-effectiveness of birth cohort testing and treatment for hepatitis C virus in the United States
- (2013) Phil McEwan et al. HEPATOLOGY
- Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals
- (2013) Natasha K. Martin et al. HEPATOLOGY
- Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
- (2013) Adriaan J. van der Meer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Impact of interferon free regimens on clinical and cost outcomes for chronic hepatitis C genotype 1 patients
- (2013) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- All-oral, interferon-free treatment for chronic hepatitis C: cost-effectiveness analyses
- (2013) L. M. Hagan et al. JOURNAL OF VIRAL HEPATITIS
- Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial
- (2013) Eric Lawitz et al. LANCET
- Hepatitis C in the United States
- (2013) Scott D. Holmberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost-Effectiveness Analysis of Boceprevir for the Treatment of Chronic Hepatitis C Virus Genotype 1 Infection in Portugal
- (2013) Elamin H. Elbasha et al. Applied Health Economics and Health Policy
- Baseline Characteristics and Mortality Among People in Care for Chronic Viral Hepatitis: The Chronic Hepatitis Cohort Study
- (2012) Anne C. Moorman et al. CLINICAL INFECTIOUS DISEASES
- Cost-effectiveness and Population Outcomes of General Population Screening for Hepatitis C
- (2012) Phillip O. Coffin et al. CLINICAL INFECTIOUS DISEASES
- Hepatitis B and C Virus Infection Among 1.2 Million Persons With Access to Care: Factors Associated With Testing and Infection Prevalence
- (2012) P. R. Spradling et al. CLINICAL INFECTIOUS DISEASES
- Chronic hepatitis C virus (HCV) disease burden and cost in the United States
- (2012) Homie Razavi et al. HEPATOLOGY
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- Economic model of a birth cohort screening program for hepatitis C virus
- (2011) Lisa J. McGarry et al. HEPATOLOGY
- Structural Frameworks and Key Model Parameters in Cost-Effectiveness Analyses for Current and Future Treatments of Chronic Hepatitis C
- (2011) Rebecca Townsend et al. VALUE IN HEALTH
- Public health impact of antiviral therapy for hepatitis C in the United States
- (2009) Michael L. Volk et al. HEPATOLOGY
- Hepatitis C treatment completion rates in routine clinical care
- (2009) Adeel A. Butt et al. LIVER INTERNATIONAL
- Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression
- (2008) Hla-Hla Thein et al. HEPATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started